| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2000;69:381-387
© 2000 The Society of Thoracic Surgeons
a Heart and Lung Transplant Service, Alfred Hospital, Victoria, Australia
Address reprint requests to Dr. Esmore, Heart and Lung Transplant Service, Commercial Rd, Prahran, Victoria 3181, Australia
Background. Lung transplantation, with and without intracardiac repair for pulmonary hypertension (PH) and Eisenmenger’s syndrome (EIS), has become an alternative transplant strategy to combined heart and lung transplantation (HLT).
Methods. Thirty-five patients with PH or EIS underwent either bilateral sequential single lung transplantation (BSSLT, group I, n = 13) or HLT (group II, n = 22). Another 74 patients, who underwent BSSLT for other indications, served as controls (group III). Immediate allograft function, early and medium-term outcomes, lung function, and 2-year survival were compared between the groups.
Results. Comparisons between groups I and II showed no significant difference in any variables except percent predicted forced vital capacity. Immediate allograft function was significantly inferior (p < 0.05) and the blood loss was greater (p < 0.01) in group I when compared with those in group III. However, this resulted in no significant difference in early and medium-term outcomes, and 2-year survival between the 2 groups.
Conclusions. BSSLT for PH and EIS can be performed as an alternative procedure to HLT without an increase in early and medium-term morbidity and mortality. Results are comparable with BSSLT performed for other indications.
This article has been cited by other articles:
|
|
 |
|
  H. B. Bittner, C. Binner, S. Lehmann, T. Kuntze, A. Rastan, and F. W. Mohr Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 462 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Benza, B. K. Rayburn, J. A. Tallaj, C. S. Coffey, L. J. Pinderski, S. V. Pamoukian, and R. C. Bourge Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease. Chest, April 1, 2006; 129(4): 1009 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Russell, K. Rouine-Rapp, G. Stratmann, and W. C. Miller-Hance Congenital heart disease in the adult: a review with internet-accessible transesophageal echocardiographic images. Anesth. Analg., March 1, 2006; 102(3): 694 - 723. [Full Text] [PDF]
|
|
|
|
 |
|
 S.M. Studer, R.D. Levy, K. McNeil, and J.B. Orens Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness Eur. Respir. J., October 1, 2004; 24(4): 674 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pereszlenyi, G. Lang, H. Steltzer, H. Hetz, A. Kocher, P. Neuhauser, W. Wisser, and W. Klepetko Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 858 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Stoica, K. D. McNeil, K. Perreas, L. D. Sharples, D. K. Satchithananda, S. S. Tsui, S. R. Large, and J. Wallwork Heart-lung transplantation for Eisenmenger syndrome: early and long-term results Ann. Thorac. Surg., December 1, 2001; 72(6): 1887 - 1891. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
